Effect of darbepoetin alfa on endothelial progenitor cells and vascular reactivity in chronic kidney disease

Vascular Medicine

Volumn 16, Issue 3, 2011, Pages 183-189

  Mohler III, Emile R ^a   Lifeng Zhang, ^a   Medenilla, Elizabeth ^a   Rogers, Wade ^a   French, Benjamin ^a   Bantly, Andrew ^a   Moore, Jonni S ^a   Yonghong Huan, ^b   Murashima, Miho ^b   Berns, Jeffrey S ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

angiogenesis; chronic kidney disease; diabetes; endothelium

Indexed keywords

CD133 ANTIGEN; CD146 ANTIGEN; CD34 ANTIGEN; NOVEL ERYTHROPOIESIS STIMULATING PROTEIN;

ADULT; AGED; ARTICLE; BLOOD VESSEL REACTIVITY; CARDIOVASCULAR FUNCTION; CELL ACTIVITY; CELL FUNCTION; CELL PROLIFERATION; CELL STIMULATION; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; COLONY FORMING UNIT; ENDOTHELIAL PROGENITOR CELL; HUMAN; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; ULTRASOUND; VASODILATATION;

AGED; ANTIGENS, CD; ANTIGENS, CD34; BIOLOGICAL MARKERS; CELL PROLIFERATION; CHRONIC DISEASE; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; ENDOTHELIAL CELLS; ERYTHROPOIETIN; FEMALE; GLYCOPROTEINS; HEMATINICS; HUMANS; KIDNEY DISEASES; LINEAR MODELS; MALE; MIDDLE AGED; PEPTIDES; PHILADELPHIA; PROSPECTIVE STUDIES; STEM CELLS; TIME FACTORS; TREATMENT OUTCOME; VASODILATION;

EID: 79959192344     PISSN: 1358863X     EISSN: 14770377     Source Type: Journal    
DOI: 10.1177/1358863X11408639     Document Type: Article

References (35)

1. Go AS, Chertow GM, Fan D., McCulloch CE, Hsu CY Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004 ; 351: 1296-1305.
2. DeLoach SS, Mohler ER 3rd. Peripheral arterial disease: a guide for nephrologists. Clin J Am Soc Nephrol 2007 ; 2: 839-846.
3. Asahara T., Murohara T., Sullivan A., et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997 ; 275: 964-967. (Pubitemid 27087709)
4. Peichev M., Naiyer AJ, Pereira D., et al. Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. Blood 2000 ; 95: 952-958. (Pubitemid 30062717)
5. Kalka C., Masuda H., Takahashi T., et al. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc Natl Acad Sci U S A 2000 ; 97: 3422-3427. (Pubitemid 30183318)
6. Vasa M., Fichtlscherer S., Aicher A., et al. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res 2001 ; 89: E1 - E7.
7. Vasa M., Fichtlscherer S., Adler K., et al. Increase in circulating endothelial progenitor cells by statin therapy in patients with stable coronary artery disease. Circulation 2001 ; 103: 2885-2890. (Pubitemid 32578123)
8. Hill JM, Zalos G., Halcox JP, et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 2003 ; 348: 593-600. (Pubitemid 36204953)
9. Bahlmann FH, DeGroot K., Duckert T., et al. Endothelial progenitor cell proliferation and differentiation is regulated by erythropoietin. Kidney Int 2003 ; 64: 1648-1652. (Pubitemid 37323692)
10. Bahlmann FH, Song R., Boehm SM, et al. Low-dose therapy with the long-acting erythropoietin analogue darbepoetin alpha persistently activates endothelial Akt and attenuates progressive organ failure. Circulation 2004 ; 110: 1006-1012. (Pubitemid 39128626)
11. Heeschen C., Aicher A., Lehmann R., et al. Erythropoietin is a potent physiologic stimulus for endothelial progenitor cell mobilization. Blood 2003 ; 102: 1340-1346. (Pubitemid 36988041)
12. Mohler ER 3rd, Shi Y., Moore J., et al. Diabetes reduces bone marrow and circulating porcine endothelial progenitor cells, an effect ameliorated by atorvastatin and independent of cholesterol. Cytometry A 2009 ; 75: 75-82.
13. Fadini GP, Sartore S., Albiero M., et al. Number and function of endothelial progenitor cells as a marker of severity for diabetic vasculopathy. Arterioscler Thromb Vasc Biol 2006 ; 26: 2140-2146. (Pubitemid 44253800)
14. Singh AK, Szczech L., Tang KL, et al. Correction of anemia with epoetin alfa in chronic kidney disease. N Engl J Med 2006 ; 355: 2085-2098. (Pubitemid 44749317)
15. Drueke TB, Locatelli F., Clyne N., et al. Normalization of hemoglobin level in patients with chronic kidney disease and anemia. N Engl J Med 2006 ; 355: 2071-2084. (Pubitemid 44749316)
16. Pfeffer MA, Burdmann EA, Chen CY, et al. A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease. N Engl J Med 2009 ; 361: 2019-2032.
17. Solomon SD, Uno H., Lewis EF, et al. Erythropoietic response and outcomes in kidney disease and type 2 diabetes. N Engl J Med 2010 ; 363: 1146-1155.
18. Ingram DA, Mead LE, Moore DB, Woodard W., Fenoglio A., Yoder MC Vessel wall-derived endothelial cells rapidly proliferate because they contain a complete hierarchy of endothelial progenitor cells. Blood 2005 ; 105: 2783-2786. (Pubitemid 40446270)
19. Shaffer RG, Greene S., Arshi A., et al. Flow cytometric measurement of circulating endothelial cells: the effect of age and peripheral arterial disease on baseline levels of mature and progenitor populations. Cytometry B Clin Cytom 2006 ; 70: 56-62.
20. Gerhard-Herman M., Gardin JM, Jaff M., Mohler E., Roman M., Naqvi TZ Guidelines for noninvasive vascular laboratory testing: a report from the American Society of Echocardiography and the Society of Vascular Medicine and Biology. J Am Soc Echocardiogr 2006 ; 19: 955-972. (Pubitemid 44118703)
21. Herbrig K., Pistrosch F., Oelschlaegel U., et al. Increased total number but impaired migratory activity and adhesion of endothelial progenitor cells in patients on long-term hemodialysis. Am J Kidney Dis 2004 ; 44: 840-849. (Pubitemid 39445916)
22. Eizawa T., Murakami Y., Matsui K., et al. Circulating endothelial progenitor cells are reduced in hemodialysis patients. Curr Med Res Opin 2003 ; 19: 627-633. (Pubitemid 37288070)
23. Choi JH, Kim KL, Huh W., et al. Decreased number and impaired angiogenic function of endothelial progenitor cells in patients with chronic renal failure. Arterioscler Thromb Vasc Biol 2004 ; 24: 1246-1252. (Pubitemid 38880016)
24. de Groot K., Bahlmann FH, Sowa J., et al. Uremia causes endothelial progenitor cell deficiency. Kidney Int 2004 ; 66: 641-646. (Pubitemid 38982006)
25. Cheng S., Cohen KS, Shaw SY, et al. Association of colony-forming units with coronary artery and abdominal aortic calcification. Circulation 2010 ; 122: 1176-1182.
26. Fadini GP, Albiero M., Boscaro E., Agostini C., Avogaro A. Endothelial progenitor cells as resident accessory cells for post-ischemic angiogenesis. Atherosclerosis 2009 ; 204: 20-22.
27. Krenning G., Dankers PY, Drouven JW, et al. Endothelial progenitor cell dysfunction in patients with progressive chronic kidney disease. Am J Physiol Renal Physiol 2009 ; 296: F1314-1322.
28. Dimmeler S., Aicher A., Vasa M., et al. HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway. J Clin Invest 2001 ; 108: 391-397. (Pubitemid 32730785)
29. Llevadot J., Murasawa S., Kureishi Y., et al. HMG-CoA reductase inhibitor mobilizes bone marrow-derived endothelial progenitor cells. J Clin Invest 2001 ; 108: 399-405. (Pubitemid 32730786)
30. Aicher A., Heeschen C. Nonbone marrow-derived endothelial progenitor cells: what is their exact location? Circ Res 2007 ; 101: e102.
31. Rivard A., Silver M., Chen D., et al. Rescue of diabetes-related impairment of angiogenesis by intramuscular gene therapy with adeno-VEGF. Am J Pathol 1999 ; 154: 355-363. (Pubitemid 29094086)
32. Liao JK Beyond lipid lowering: the role of statins in vascular protection. Int J Cardiol 2002 ; 86: 5-18. (Pubitemid 35247880)
33. Bahlmann FH, de Groot K., Spandau JM, et al. Erythropoietin regulates endothelial progenitor cells. Blood 2004 ; 103: 921-926. (Pubitemid 38129551)
34. Schmidt-Lucke C., Rossig L., Fichtlscherer S., et al. Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: proof of concept for the clinical importance of endogenous vascular repair. Circulation 2005 ; 111: 2981-2987. (Pubitemid 40814192)
35. Chade AR, Zhu X., Lavi R., et al. Endothelial progenitor cells restore renal function in chronic experimental renovascular disease. Circulation 2009 ; 119: 547-557.